Cutler Group’s Surmodics SRDX Stock Holding History

Cutler Group’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$9K	–	7162
2016 Q4	$9K	Buy	+1,000	New	+$26.3K	﹤0.01%	4347
2016 Q1	–	Sell	-1,200	Closed	-$11K	–	7157
2015 Q4	$11K	Buy	+1,200	New	+$25.5K	﹤0.01%	4062

Other funds holding SRDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cutler Group's SRDX Position: Q1 2017 in Review

Cutler Group sold out of Surmodics (SRDX) in Q1 2017, closing a stake of 601 shares — an estimated $15K sold.

Cutler Group first reported a position in SRDX in Q4 2015 and held it in 3 quarters. The position peaked at $23K in Q4 2015. 111 funds tracked by Wall St. Rank hold SRDX as of Q1 2017.

Cutler Group reported no remaining Surmodics position as of Q1 2017 after selling out during the quarter.
Cutler Group sold 601 Surmodics shares in Q1 2017, an estimated $15K.
Cutler Group first reported a position in Surmodics in Q4 2015 and held it in 3 quarters.
Cutler Group's Surmodics position peaked at $23K in Q4 2015.
111 funds tracked by Wall St. Rank held Surmodics as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.